Skip to content

Evaluation of nitroglycerine and lidocaine ointment on the pain caused by catheterization in neonates

Investigation of the effect of 2% nitroglycerin ointment - 2% lidocaine on the pain control due to intravenous catheter in infants; randomized double-blind clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190810044500N19
Enrollment
84
Registered
2021-08-22
Start date
2021-08-23
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Measurement of pain during catheterization in infants.

Interventions

Intervention 1: Intervention group: Topical nitroglycerin ointment 2% - lidocaine 2%, one gram with an area of one square centimeter, on the infant venous site, apply and then wait for 10 minutes and

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 1 Months

Inclusion criteria

Inclusion criteria: Infants with non-complicated cesarean delivery or normal birth gestational age greater than 34 weeks and postnatal age less than 4 weeks need to intravenous catheterization

Exclusion criteria

Exclusion criteria: Parents' dissatisfaction with their baby's participation in the study

Design outcomes

Primary

MeasureTime frame
Pain score of catheterization. Timepoint: After catheterization. Method of measurement: PIPP Score.;How long the baby cries after catheterization. Timepoint: After catheterization. Method of measurement: The duration of the baby's crying is recorded in seconds.;How long it takes for the baby to start crying. Timepoint: during catheterization. Method of measurement: The time it takes for a baby to start crying is recorded in seconds.;How long the procedure lasts. Timepoint: during catheterization. Method of measurement: The duration of the procedure is recorded in seconds.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Saghafi

Yazd University of Medical Sciences

F.saghafi@ssu.ac.ir+98 35 3419 3820

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026